SEC 13F Intelligence

Lion Point Capital, LP / RGNX

Lion Point Capital, LP’s Regenxbio Inc Position

Does Lion Point Capital, LP own Regenxbio Inc (RGNX)? Yes — 26.6K shares worth $222,908 (+1.33% of its 13F portfolio) as of Q1 2026.

Position Value
$222,908
Q1 2026
Shares
26.6K
% of Portfolio
+1.33%
Quarters Held
9
currently held

Position History RGNX

Reported value by quarter
Q1 ’24: $684,775Q1 ’24Q2 ’24: $424,125Q3 ’24: $605,798Q3 ’24Q4 ’24: $446,408Q1 ’25: $412,913Q1 ’25Q2 ’25: $474,128Q3 ’25: $557,288Q3 ’25Q4 ’25: $383,040Q1 ’26: $222,908Q1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202626.6K$222,908+1.33%
Q4 202526.6K$383,040+1.98%
Q3 202557.8K$557,288+3.17%
Q2 202557.8K$474,128+3.22%
Q1 202557.8K$412,913+2.63%
Q4 202457.8K$446,408+2.34%
Q3 202457.8K$605,798+1.35%
Q2 202436.3K$424,125+0.77%
Q1 202432.5K$684,775+0.38%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Lion Point Capital, LP’s full portfolio or all institutional holders of RGNX.